Dier Mardi 4

What Happened Dier Mardi, Executive Vice President and Chief Financial Officer of Madrigal Pharmaceuticals (MDGL), sold 1,183 shares on 2026-03-02 at $427.21 per share, generating proceeds of $505,389. The filing indicates the sale was executed to satisfy tax withholding obligations tied to the vesting of restricted stock units, not as a discretionary open-market trade.

Key Details

• Transaction date and price: 2026-03-02 at $427.21 per share
• Shares sold / proceeds: 1,183 shares / $505,389 total
• Shares owned after transaction: Not reported in this Form 4
• Footnote: Sale was automatic to cover tax withholding for vested RSUs (not at the reporting person’s discretion)
• Filing timeliness: Reported on 2026-03-02 (same-day filing; no late filing indicated)

Context This was a routine "sell to cover" tied to RSU vesting, a common administrative transaction to satisfy tax liabilities. Such sales are not strong indicators of insider sentiment because they are mandatory or automated rather than voluntary stock-selling decisions.